Results 1 to 10 of about 125 (99)

Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force. [PDF]

Bipolar Disord, 2022
Abstract Background Cognitive impairments are an emerging treatment target in mood disorders, but currently there are no evidence‐based pro‐cognitive treatments indicated for patients in remission. With this systematic review of randomised controlled trials (RCTs), the International Society for Bipolar Disorders (ISBD) Targeting Cognition Task force ...
Miskowiak KW, Seeberg I, Jensen MB, Balanzá-Martínez V, Del Mar Bonnin C, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Lafer B, Lewandowski KE, López-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes P, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Kessing LV, Burdick KE, Vieta E.   +27 more
europepmc   +7 more sources

ISBD (CR): International Standard Bibliographic Descr

Knjižnica, 2005
The article presents the new concept of continuing resources, covering serial publications and integrating resources, and describes important, international decisions which derive from the expansion of standard coverage, especially as the consequence of ...
Irena Kavčič, Dunja Kalčič
doaj   +3 more sources

Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force. [PDF]

Bipolar Disord, 2022
Abstract Background Developing treatments for cognitive impairment is key to improving the functioning of people with mood disorders. Neuroimaging may assist in identifying brain‐based efficacy markers. This systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force examines the evidence from ...
Miskowiak KW, Yalin N, Seeberg I, Burdick KE, Balanzá-Martínez V, Bonnin CDM, Bowie CR, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Kessing LV, Lafer B, Lewandowski KE, López-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Stokes PRA.   +27 more
europepmc   +2 more sources

Consensus on Subdomains and Measures of Relevance to Affective and Social Cognition Research on Bipolar Disorder (CAS-BD); Outcomes and Recommendations From an International Society for Bipolar Disorders Targeting Cognition Taskforce Study. [PDF]

Bipolar Disord
ABSTRACT Background The Consensus on subdomains and measures of Affective and Social cognition for research on Bipolar Disorder (CAS‐BD) project aimed to formulate preliminary consensus‐based recommendations for assessing affective and social cognition in BD.
Van Rheenen TE, Lewandowski KE, Pinkham A, Varo C, Caruana G, Gruber J, Zarp J, Young AH, Yatham LN, Vieta E, Torres IJ, Tsapekos D, Sumiyoshi T, Stokes PRA, Schaffer A, Purdon S, Porter RJ, McIntyre RS, Martinez-Aran A, López-Jaramillo C, Lafer B, Kessing LV, Kjærstad HL, Hasler G, Gallagher P, Douglas K, Dols A, Carvalho AF, Burdick KE, Bowie CR, Bonnin CM, Balanzá-Martínez V, Miskowiak KW.   +32 more
europepmc   +2 more sources

Predicting Response to Pro-Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force. [PDF]

Acta Psychiatr Scand
ABSTRACT Introduction Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.
Tsapekos D, Kalfas M, Schandorff JM, Del Mar Bonnin C, Bowie CR, Balanzá-Martínez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Hasler G, Kessing LV, Kjærstad HL, Lafer B, Lewandowski KE, López-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Zarp J, Young AH, Vieta E, Miskowiak KW.   +30 more
europepmc   +2 more sources

Impact of Activation Therapy for Inpatients With Major Depression: Primary and Secondary Outcomes From a Randomised Controlled Trial. [PDF]

Bipolar Disord
ABSTRACT Introduction Inpatient depression is associated with high morbidity and significant cognitive impairment. Inpatient treatment often focuses on short‐term stabilization with medication. Readmission rates are high. We examined the impact of a novel psychological intervention, activation therapy (AT, Behavioural Activation combined with Cognitive
Douglas KM, Odering ZA, Jordan J, Crowe MT, Lacey CJ, Frampton CM, Averill IRE, Hamel CS, Bowie CR, Porter RJ.   +9 more
europepmc   +2 more sources

The new resources on the Internet and their taxonomy

Knjižnica, 2004
The article describes new resources on the Internet and their taxonomy. The revised standard ISBD(CR) for continuing resources is presented, together with changes and differences in the bibliographic description of serials versus integrating resources ...
Dunja Kalčič
doaj   +3 more sources

Management of hypertension in high-risk ethnic minority with heart failure. [PDF]

Int J Hypertens, 2011
Hypertension (HTN) is the most common co‐morbidity in the world, and its sequelae, heart failure (HF) is one of most common causes of mortality and morbidity in the world. Current understanding of pathophysiology and management of HTN in HF is mainly based on studies, which have mainly included whites.
Demede M, Pandey A, Innasimuthu L, Jean-Louis G, McFarlane SI, Ogedegbe G.   +5 more
europepmc   +2 more sources

The screen for cognitive impairment in psychiatry in patients with borderline personality disorder

Personality and Mental Health, Volume 16, Issue 4, Page 279-289, November 2022., 2022
Abstract Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients.
Federica Folesani, Martino Belvederi Murri, Bruno Biancosino, Silvia Costa, Luigi Zerbinati, Rosangela Caruso, Maria Giulia Nanni, Tommaso Toffanin, Maria Ferrara, Scot E. Purdon, Luigi Grassi   +10 more
wiley   +1 more source

A 6‐month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar‐specific educational control in poorly adherent adolescents and young adults living with bipolar disorder

Bipolar Disorders, Volume 26, Issue 7, Page 696-707, November 2024.
Abstract Objective Few studies have addressed medication adherence in adolescents and young adults (AYAs) with bipolar disorder (BD). This 6‐month prospective randomized‐controlled trial (RCT) tested customized adherence enhancement for adolescents and young adults (CAE‐AYA), a behavioral intervention for AYAs versus enhanced treatment as usual (ETAU).
Jennifer B. Levin, Melissa DelBello, Avani C. Modi, Farren Briggs, Larry F. Forthun, Molly McVoy, Joy Yala, Raechel Cooley, Jessica Black, Carla Conroy, Martha Sajatovic   +10 more
wiley   +1 more source